delisting

Li & Fung in $564 million deal to privatise IDS

Li & Fung aims to consolidate its affiliate logistics company Integrated Distribution Services to further strengthen its China position and its distribution capabilities.
August 15, 2010

MBK Partners pursues Chinese pharmaceuticals firm

The private equity firm will acquire Singapore-listed Chinese drug maker, AsiaPharm, for $252 million. Shareholders respond by pushing the traded share price up to near offer level.
February 10, 2008